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In plants and invertebrates, Dicer genes play a critical role against infections by RNA viruses. In this
issue, Otsuka et al. (2007) report that Dicer mutant mice are hypersusceptible to infection by the RNA
virus VSV.Viruses are the most abundant patho-
gens on earth, and resistance of cells
to infection depends on their capacity
to detect and control the replication
of viral nucleic acids. In plants and
invertebrates, long double stranded
(ds) RNAs are recognized and pro-
cessed by members of the Dicer
family. These endoribonuclease III
enzymes generate 21–25 base pair
small interfering (si) RNA duplexes.
One strand of the duplex, the ‘‘guide’’
strand, is then transferred to an effector
complex, the RNA-induced silencing
complex or RISC, whereas the ‘‘pas-
senger’’ strand is degraded. The RISC
complex contains a member of the
Argonaute family, which cleaves the
RNA molecules targeted by the guide
strand. This scheme enables host cells
to detect dsRNAs, a hallmark of repli-
cation of many viruses, and to activate
a nuclease that relies on the base pair-
ing of complementary sequences to
specifically degrade viral genomes. In
plants, the Dicer-like (DCL) enzymes
DCL-2, DCL-3, and DCL-4 respectively
produce 22 bp, 24 bp, and 21 bp siR-
NAs that confer antiviral immunity
(Deleris et al., 2006), whereas in flies,
production of siRNAs is mediated by
Dicer-2,which is required for resistance
toRNA virus infections (Galiana-Arnoux
et al., 2006; van Rij et al., 2006; Wang
et al., 2006). MicroRNAs (miRNAs)
represent another class of small RNAs
mediating gene silencing. They are
generated by additional members of
the Dicer family (DCL-1 in Arabidopsis,
Dicer-1 in Drosophila), which process
endogenous hairpin-containing RNAs
(pre-miRNAs) (Figure 1).
In mammals, dsRNAs do not appear
to trigger RNA interference. Rather,these molecules are detected by
specific receptors (Toll-like receptor
3 or RIG-like helicases) that activate
signaling and lead to induction of
type I interferons. These cytokines in
turn induce the production of effector
molecules, such as RNaseL and pro-
tein kinase R (PKR), that will degrade
viral RNAs and block their translation.
In contrast to the situation in plants
and invertebrates, siRNAs have not
been detected in virus-infected mam-
malian cells, and the unique Dicer
gene in mammals mediates the pro-
duction of miRNAs. Interestingly,
some of these miRNAs play an active
role in the control of specific viral infec-
tions. These miRNAs can be of viral or
cellular origin and target viral or cellular
genes (Figure 1). Simian virus 40,
a member of the polyomavirus family,
encodes miRNAs that target the gene
encoding a major viral protein, the T
antigen. The T antigen is a dominant
target of the cytotoxic T lymphocyte
(CTL) response, and downregulation
of its expression decreases the CTL-
mediated lysis of infected cells (Sulli-
van et al., 2005). Another DNA virus,
Herpes simplex virus-1 (HSV-1), pro-
vides an example of a viral miRNA
targeting a cellular gene. A remarkable
feature of HSV-1 is that it can establish
latent infections and remains unde-
tected in some cells of an infected
organism for years. The viral latency-
associated transcript (LAT) plays a
critical role in this phenomenon, by
inhibiting apoptosis of infected cells.
A miRNA, miR-LAT, is produced from
LAT and targets the cellular mRNAs
encoding two components of the
TGF-b pathway (TGF-b itself and the
transcription factor SMAD3), whichImmregulates cell proliferation and pro-
grammed cell death (Gupta et al., 2006).
So there is no doubt that viral
miRNAs can control expression of viral
or cellular genes to interfere with anti-
viral host defense. But can cellular
miRNAs—and Dicer—regulate viral
infections? Two reports suggest that
this is indeed the case for retroviruses:
Human immunodeficiency virus (HIV)-
1 replicates more efficiently and with
faster kinetics in cells silenced for
Dicer or Drosha, which control two
distinct steps in the synthesis of miR-
NAs. The anti-HIV effects of Dicer
and Drosha are mediated by two cellu-
lar miRNAs, miR-17-5p and miR-20a,
which target the gene encoding the
histone acetylase PCAF, an important
cellular cofactor of the HIV-1 transacti-
vator Tat. The biological significance
of this finding is underlined by the
fact that HIV-1 actively suppresses ex-
pression of miR-17-5p and miR-20a
(Triboulet et al., 2007). The second
example is even more interesting
because it involves a cellular miRNA,
miR-32, which targets a sequence in
the genome of the primate foamy virus
type 1 (PFV-1). As a countermeasure,
PFV-1 expresses the protein Tas,
a suppressor of miRNA-directed
silencing (Lecellier et al., 2005). In this
issue of Immunity, Otsuka et al.
(2007) now extend these findings and
demonstrate that two other miRNAs,
miR24 and miR93, target the RNA
genome of the rhabdovirus vesicular
stomatitis virus (VSV). Importantly,
this study addresses for the first time
the in vivo contribution of miRNAs to
antiviral host defense.
The authors have generated
a mouse mutant with hypomorphicunity 27, July 2007 ª2007 Elsevier Inc. 1
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PreviewsFigure 1. Schematic Representation of the Involvement of Dicer and MicroRNAs in
the Control of Viral Infections in Mammals
Hairpin-containing pri-miRNAs are transcribed from viral or cellular genes by RNA polymerase II,
and processed in the nucleus by the RNase III enzyme Drosha, to generate pre-miRNAs. These
precursors are exported to the cytoplasm, where they are further processed by Dicer, another
RNase III enzyme, to generate duplex miRNAs. One strand of the duplex is incorporated into
the RISC effector complex, which will target mRNAs bearing homology to the miRNA. Viral
sequences are shown in red, and cellular sequences are shown in green. Viral miRNAs target viral
genes to modulate expression of viral antigens or target cellular genes to interfere with the host
response to infection. Dicer also regulates viral infections by producing cellular miRNAs that
regulate expression cellular genes required for viral replication. Finally, some cellular miRNAs
regulate the viral load in infected cells by targeting viral sequences. The conservation of the
miR-24 and miR-93 target sequences in the VSV genome suggests that this regulation may offer
some advantage to the virus.Dicer expression (Dicer1d/d mice). The
low expression of wild-type Dicer in
these mice is apparently sufficient to
bypass the embryonic lethality ob-
served in Dicer null mutant mice and
to obtain viable adults. In agreement
with this hypothesis, low amounts of
Dicer protein can be detected in
some mouse tissues but, importantly,
not in peritoneal macrophages, which
were used to test the role of Dicer in
the control of viral infections. When
tested by infection with a panel of
viruses, Dicer1d/d-deficient macro-
phages were found to produce sub-
stantially greater titers of VSV and
HSV-1 than macrophages from wild-
type mice. Replication of several other2 Immunity 27, July 2007 ª2007 ElsevierRNA or DNA viruses was similar in the
two populations of macrophages,
ruling out a general role of Dicer in an-
tiviral immunity in mammals (Otsuka
et al., 2007). The greater production
of HSV-1 in Dicer-deficient cells is
consistent with the antiapoptotic role
of the viral miR-LAT (Gupta et al.,
2006). In the case of VSV, increased
viral replication in Dicer1d/d macro-
phages is not due to a defect in in-
duction of interferon or in interferon
responses. Rather, the phenotype
can be attributed to the synthesis in
macrophages of two miRNAs, which
target the VSV genome (Figure 1).
MiR-24 reduces expression of the L
gene, which encodes the viral poly-Inc.merase, whereas miR-93 acts on the
P gene, which encodes a cofactor for
the polymerase. Both genes are es-
sential for the replication of the virus,
as shown by the increase of all viral
RNAs and proteins in Dicerd/d cells.
The authors elegantly demonstrated
that defective synthesis of miR-24
and miR-93 explains the increased
viral load in VSV-infectedDicerd/dmac-
rophages, by introducing two point
mutations in the seed sequences rec-
ognized by the miRNAs in the viral
genome and showing that these
mutants, which can no longer be tar-
geted by the miRNAs, grow to greater
titers in wild-type but not in Dicer mu-
tant macrophages. In contrast to pre-
vious studies, which were carried out
in tissue-culture cells, Otsuka et al.
(2007) demonstrate that the absence
of Dicer in macrophages, or mutations
of the miR-24 and miR-93 target sites
in the VSV genome, result in increased
lethality of mice after intranasal chal-
lenge with the virus. This exacerbated
sensitivity to VSV correlates with
increased severity of interstitial pneu-
monitis and a 50- to 100-fold increase
in viral titer in the brains of infected
Dicerd/d mice (Otsuka et al., 2007).
The present study demonstrates
that cellular miRNAs generated by
Dicer can contribute to the outcome
of a viral infection in mice, by targeting
the viral genome. But how does this
compare to other antiviral responses
in mammals or to the antiviral function
of Dicer-2 in flies? Clearly, the effects
of the Dicer deficiency in mice are
modest (5- to 10-fold increase in viral
titer in peritoneal macrophages) com-
pared to other mutations that affect
innate sensing of viruses or type I inter-
feron signaling. Moreover, Dicer-2 in
flies has broad anti-RNA virus func-
tions, whereas in mice, VSV (and to
a lower extent HSV-1) was the only
virus among the seven tested that are
affected by the absence of Dicer in
peritoneal macrophages. This reflects
the complementarity of the sequences
of miR-24 and miR-93 with the VSV
genome and raises the question of
why the virus has not adapted to its
host by changing the sequences
targeted by the two miRNAs, espe-
cially given the high error rate of viral
RNA-dependent RNA polymerases.
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nomes of the two major serotypes of
VSV, called Indiana (used by Otsuka
et al. [2007]) and New Jersey, reveals
that the miR-24 and miR-93 target sites
are not conserved in the New Jersey
serotype. This is especially striking
for miR-24, which targets a highly con-
served region of the genome, encod-
ing the viral polymerase. The New Jer-
sey strain contains a mutation at the
same position as that selected by Ot-
suka et al. (2007) to inactivate miR-24
targeting, resulting in disruption of the
seed binding of the miRNA, without
affecting the coding sequence of the
L gene. This illustrates how hazardous
it would be for the host to rely on
miRNAs to target viruses and ques-
tions whether the interaction of miR-24
and miR-93 with the genome of the
Indiana serotype of VSV represents
an adaptation of the virus to its host,
rather than a defense mechanism.
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signaling in the expression of G
Notch signaling controls cell-differen-
tiation processes in a wide variety of
tissues throughout the life of multicel-
lular organisms, including the lineage
choice between T and B lymphocytes
made by hematopoietic progenitors
as they become more differentiated.
Notch is a heterodimeric surface re-
ceptor consisting of an extracellular
ligand-binding region noncovalently
associated with a transmembrane
polypeptide with a long intracellular
tail. Mammals have four differentquantity of viral RNAs in infected cells,
and control the extent of the inflamma-
tory response, to protect its host. In-
deed, field isolates of the New Jersey
serotype have been shown to induce
on average a ten-fold greater inter-
feron response than isolates of the In-
diana serotype (Marcus et al., 1998).
In conclusion, further studies are
required to fully understand the role
of Dicer and miRNAs in the intricate
relationships between viruses and
their mammalian hosts. No doubt that
the Dicer-deficient mice described by
Otsuka et al. (2007) will be a valuable
asset to achieve this goal.
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